Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in May 2025.
- Notable investors include Brabantse Ontwikkelings Maatschappij, Rabo Investments, Brabant Startup Fund, Innovation Industries (Amsterdam), Medtech Ttt — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Aikon Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Aikon Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aikon Health
Developer of a personalized heart failure management technology designed to revolutionize heart failure care through technology. The company offers a proprietaryheart failure monitoring device, which is a cutting-edge wearable integrated with digital health solutions and is designed to empower cardiologists and nurses in precise medication titration and effective management of heart failure patients, enabling customers to elevate patient care and reduce hospital readmissions for heart failure patients.
- Sector
- Healthcare
- HQ
- Eindhoven, Netherlands
- Founded
- 2023
- Employees
- 5
- Website
- aikonhealth.com/
- Ownership
- Privately Held (backing)
Aikon Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aikon Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aikon Health in its N-PORT filings yet. We sweep new filings monthly.